Breaking News Headlines Today

News about GLP-1

Stay current with all the latest and breaking news about GLP-1, compare headlines and perspectives between news sources on stories happening today. In total, 53 stories have been published about GLP-1 which Ground News has aggregated in the past 3 months.

Covered Most By

endpoints.news

Unknown

Anti-Aging, Acupuncture and Health News

Local News Publishers

Suggest a source

Looking for a source we don't already have? Suggest one here.

Top GLP-1 News

GLP-1 · United States

Trump Announces Cost Cuts to Weight Loss Drugs

55% Center coverage: 282 sources

U.S. President Donald Trump announced agreements with pharmaceutical companies Novo Nordisk and Eli Lilly to reduce prices for their obesity drugs Wegovy and Zepbound, respectively, including $50 monthly copays for Medicare patients starting mid-2026 and expanded coverage for those with severe obesity.See the Story

United States · United States

President Trump Unveils Deal to Expand Coverage, Lower Costs on GLP-1 Obesity Drugs Like Wegovy

64% Center coverage: 22 sources

President Donald Trump unveiled a deal Thursday with drugmakers Eli Lilly and Novo Nordisk to expand coverage and reduce prices for their popular obesity treatments Zepbound and Wegovy.See the Story

United States · United States

Sam Altman says he tried semaglutide 'before it was cool' — and once ended up in a hospital

100% Left coverage: 1 sources

"Sometimes late at night, you just really want that chocolate chip cookie at 11:30," Sam Altman said.Sebastian Gollnow/picture alliance via Getty ImagesOpenAI CEO Sam Altman said that he tried semaglutide "before it was cool" — and that it sent him to the hospital.Semaglutide is sold under brand names like Ozempic and Wegovy. Elon Musk has also said he tried it."I now do basically nothing," Altman told Tyler Cowen. "I eat junk food. I don't exer…Sam Altman · San Francisco Read Article

Eli Lilly’s next-gen weight-loss drug offers a new hope

100% Left coverage: 1 sources

The once-weekly shot may be a tempting alternative to popular GLP-1 class drugs like Ozempic and WegovyHealth · United Kingdom See the Story

Hopeful Lipid-Busters to Watch at AHA: New GLP-1, Gene Therapy, Oral PCSK9 Inhibitor

(MedPage Today) — NEW ORLEANS — Innovations in lipid lowering get a major chance to shine, and potentially move the needle in cardiometabolic treatment, this weekend here at the American Heart Association (AHA) annual meeting. Spearheading… Source link : https://www.medpagetoday.com/meetingcoverage/aha/118368 Author : Publish date : 2025-11-07 16:22:00 Copyright for syndicated content belongs to the linked […] The post Hopeful Lipid-Busters to W…GLP-1 · New Orleans Read Article

From insight to impact: exploring the physical activity sector’s role in supporting GLP-1 users at ukactive’s Strategic Partner Event

By Claire Place, Member Experience Manager, ukactive Last week, ukactive brought together members of our Strategic Partner Group (SPG) for an afternoon of discussion, collaboration and connection ahead of an exciting evening celebrating the best of the best at the 2025 ukactive Awards at the ICC in Birmingham. The event was attended by ukactive Strategic Partners and the panellist session was Chaired by Dr Sonia Adesara, alongside Sarah Berne (…GLP-1 · Birmingham Read Article

Use of Obesity Drugs in Cancer Patients Increases Despite Lack of Clinical Guidance

100% Center coverage: 1 sources

(MedPage Today) -- Prescriptions for GLP-1 receptor agonists for patients with cancer have increased despite a lack of clinical guidance on the drugs' safety and efficacy in cancer, a large retrospective review of health records showed. Overall...Cancer · United States Read Article

Apparently, 'Ozempic Earlobes' Are a Thing Now, Too

100% Center coverage: 1 sources

Following the allegedly common complaints of "Ozempic face" and "Ozempic butt," a plastic surgeon claims an influx of patients are complaining of loose, saggy earlobes after losing weight with a GLP-1 medication, so we investigated if the concept of “Ozempic ears” is a stretch—or a literal lack thereof.Ozempic · Australia See the Story

Does Microdosing GLP-1s Work? Expert Weighs In

100% Center coverage: 1 sources

(MedPage Today) -- Welcome to Culture Clinic, MedPage Today's collaboration with Northwell Health to offer a healthcare professional's take on the latest viral medical topics. More companies are promoting microdosing GLP-1 receptor agonists even...GLP-1 · United States Read Article

Resmetirom Effective for MASH Irrespective of GLP-1 RA, SGLT2i Use

Resmetirom showed comparable MASH resolution and fibrosis improvement in patients on GLP-1 RA or SGLT2i therapy and those on resmetirom alone.GLP-1 Read Article

News about GLP-1

News about GLP-1

Covered Most By

Local News Publishers

Top GLP-1 News

Trump Announces Cost Cuts to Weight Loss Drugs

President Trump Unveils Deal to Expand Coverage, Lower Costs on GLP-1 Obesity Drugs Like Wegovy

Novo Nordisk Fights Back with Oral GLP-1 Data in Obesity

Questions swirl after Trump’s GLP-1 pricing deal announcement

Gustavo De Arístegui: Geopolitical Analysis of November 7, 2025

Sam Altman says he tried semaglutide 'before it was cool' — and once ended up in a hospital

Eli Lilly’s next-gen weight-loss drug offers a new hope

Hopeful Lipid-Busters to Watch at AHA: New GLP-1, Gene Therapy, Oral PCSK9 Inhibitor

From insight to impact: exploring the physical activity sector’s role in supporting GLP-1 users at ukactive’s Strategic Partner Event

Use of Obesity Drugs in Cancer Patients Increases Despite Lack of Clinical Guidance

Apparently, 'Ozempic Earlobes' Are a Thing Now, Too

Does Microdosing GLP-1s Work? Expert Weighs In

Resmetirom Effective for MASH Irrespective of GLP-1 RA, SGLT2i Use

Covered Most By

Media Bias Breakdown

Breaking News Topics Related to GLP-1

Questions swirl after Trump’s GLP-1 pricing deal announcement

Gustavo De Arístegui: Geopolitical Analysis of November 7, 2025

Sam Altman says he tried semaglutide 'before it was cool' — and once ended up in a hospital

Eli Lilly’s next-gen weight-loss drug offers a new hope

Hopeful Lipid-Busters to Watch at AHA: New GLP-1, Gene Therapy, Oral PCSK9 Inhibitor

From insight to impact: exploring the physical activity sector’s role in supporting GLP-1 users at ukactive’s Strategic Partner Event

Use of Obesity Drugs in Cancer Patients Increases Despite Lack of Clinical Guidance

Apparently, 'Ozempic Earlobes' Are a Thing Now, Too

Does Microdosing GLP-1s Work? Expert Weighs In

Resmetirom Effective for MASH Irrespective of GLP-1 RA, SGLT2i Use

News about GLP-1

News about GLP-1

Covered Most By

Local News Publishers Too Big Arrow Icon

Top GLP-1 News

Trump Announces Cost Cuts to Weight Loss Drugs

President Trump Unveils Deal to Expand Coverage, Lower Costs on GLP-1 Obesity Drugs Like Wegovy

Novo Nordisk Fights Back with Oral GLP-1 Data in Obesity

Questions swirl after Trump’s GLP-1 pricing deal announcement

Gustavo De Arístegui: Geopolitical Analysis of November 7, 2025

Sam Altman says he tried semaglutide 'before it was cool' — and once ended up in a hospital

Eli Lilly’s next-gen weight-loss drug offers a new hope

Hopeful Lipid-Busters to Watch at AHA: New GLP-1, Gene Therapy, Oral PCSK9 Inhibitor

From insight to impact: exploring the physical activity sector’s role in supporting GLP-1 users at ukactive’s Strategic Partner Event

Use of Obesity Drugs in Cancer Patients Increases Despite Lack of Clinical Guidance

Apparently, 'Ozempic Earlobes' Are a Thing Now, Too

Does Microdosing GLP-1s Work? Expert Weighs In

Resmetirom Effective for MASH Irrespective of GLP-1 RA, SGLT2i Use

Covered Most By

Media Bias Breakdown

Breaking News Topics Related to GLP-1

Questions swirl after Trump’s GLP-1 pricing deal announcement

Gustavo De Arístegui: Geopolitical Analysis of November 7, 2025

Sam Altman says he tried semaglutide 'before it was cool' — and once ended up in a hospital

Eli Lilly’s next-gen weight-loss drug offers a new hope

Hopeful Lipid-Busters to Watch at AHA: New GLP-1, Gene Therapy, Oral PCSK9 Inhibitor

From insight to impact: exploring the physical activity sector’s role in supporting GLP-1 users at ukactive’s Strategic Partner Event

Use of Obesity Drugs in Cancer Patients Increases Despite Lack of Clinical Guidance

Apparently, 'Ozempic Earlobes' Are a Thing Now, Too

Does Microdosing GLP-1s Work? Expert Weighs In

Resmetirom Effective for MASH Irrespective of GLP-1 RA, SGLT2i Use

Local News Publishers